Inhibiting SCAP/SREBP exacerbates liver injury and carcinogenesis in murine nonalcoholic steatohepatitis.
J Clin Invest. 2022 Jun 1;132(11):e151895. doi: 10.1172/JCI151895.
J Clin Invest. 2022.
PMID: 35380992
Free PMC article.